Table 4.
Outcome | Treatment | Unadjusted Rates |
Unadjusted Kaplan- Meier Rate |
Unadjusted Hazard Ratio (GIK vs. Placebo) |
95% Confidence Interval of 95% Unadjusted Hazard Ratio |
Unadjusted Cox Regression P-Value |
---|---|---|---|---|---|---|
1-Year Mortality | GIK | 13/163 (8.0%) | 8.3% | 0.65 | 0.33, 1.27 | 0.208 |
Placebo | 24/194 (12.4%) | 12.6% | ||||
Cardiac Arrest or Mortality | GIK | 17/163 (10.4%) | 10.8% | 0.52 | 0.30, 0.92 | 0.025 |
Placebo | 37/194 (19.1%) | 19.3% | ||||
In-hospital Cardiac Arrest | GIK | 9/163 (5.5%) | 0.49 | 0.23, 1.03 | 0.061 | |
Placebo | 21/194 (10.8%) | |||||
1-Year HF or Mortality | GIK | 16/163 (9.8%) | 10.2% | 0.63 | 0.35, 1.16 | 0.139 |
Placebo | 30/194 (15.5%) | 15.7% | ||||
1-Year HF | GIK | 6/163 (3.7%) | 4.2% | 0.65 | 0.24, 1.74 | 0.389 |
Placebo | 11/194 (5.7%) | 6.1% | ||||
Cardiac arrest, HF, or Mortality | GIK | 19/163 (11.7%) | 12.0% | 0.51 | 0.30, 0.87 | 0.014 |
Placebo | 42/194 (21.6%) | 21.9% |